Xeris Pharmaceuticals' IPO

Xeris Pharmaceuticals raised a round of funding on June 21, 2018. Investors include Public.

Xeris is a specialty biopharmaceutical company focused on developing improved and differentiated injectable therapeutics for multiple indications in diabetes, epilepsy, and immunology. The company's X…

Articles about Xeris Pharmaceuticals' IPO: